High PLK4 expression was associated with clinical characteristic such as IDH wildtype status, 1p/19q non-codeleted status, and demethylation of MGMT, all of which were correlated with poor prognosis in patients with glioma (Supplementary Figures 1M-U). Here, IDH1 is linked to central nervous system cancer.